These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24192662)

  • 1. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
    Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).
    Boers KE; Vijgen SM; Bijlenga D; van der Post JA; Bekedam DJ; Kwee A; van der Salm PC; van Pampus MG; Spaanderman ME; de Boer K; Duvekot JJ; Bremer HA; Hasaart TH; Delemarre FM; Bloemenkamp KW; van Meir CA; Willekes C; Wijnen EJ; Rijken M; le Cessie S; Roumen FJ; Thornton JG; van Lith JM; Mol BW; Scherjon SA;
    BMJ; 2010 Dec; 341():c7087. PubMed ID: 21177352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
    Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
    BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.
    Boers KE; van Wyk L; van der Post JA; Kwee A; van Pampus MG; Spaanderdam ME; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Rijken M; Roumen FJ; Thornton JG; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 Apr; 206(4):344.e1-7. PubMed ID: 22342897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery--correlation with short-term outcome.
    Schwarze A; Gembruch U; Krapp M; Katalinic A; Germer U; Axt-Fliedner R
    Ultrasound Obstet Gynecol; 2005 Jun; 25(6):573-9. PubMed ID: 15912468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine growth restriction at term: induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): a pilot study.
    van den Hove MM; Willekes C; Roumen FJ; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):54-8. PubMed ID: 16054286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of umbilical artery Doppler velocimetry in growth-restricted fetuses.
    Soregaroli M; Bonera R; Danti L; Dinolfo D; Taddei F; Valcamonico A; Frusca T
    J Matern Fetal Neonatal Med; 2002 Mar; 11(3):199-203. PubMed ID: 12380678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
    Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
    Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
    BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
    Ebrashy A; Azmy O; Ibrahim M; Waly M; Edris A
    Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.
    Boers KE; Bijlenga D; Mol BW; LeCessie S; Birnie E; van Pampus MG; Stigter RH; Bloemenkamp KW; van Meir CA; van der Post JA; Bekedam DJ; Ribbert LS; Drogtrop AP; van der Salm PC; Huisjes AJ; Willekes C; Roumen FJ; Scheepers HC; de Boer K; Duvekot JJ; Thornton JG; Scherjon SA
    BMC Pregnancy Childbirth; 2007 Jul; 7():12. PubMed ID: 17623077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
    Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
    BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal outcomes and maternal clinical characteristics in IUGR with absent or reversed end-diastolic flow velocity in the umbilical artery.
    Jang DG; Jo YS; Lee SJ; Kim N; Lee GS
    Arch Gynecol Obstet; 2011 Jul; 284(1):73-8. PubMed ID: 20658142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal morbidity and mortality in intrauterine growth restricted (IUGR) pregnancies is predicated upon prenatal diagnosis of clinical severity.
    Marconi AM; Ronzoni S; Vailati S; Bozzetti P; Morabito A; Battaglia FC
    Reprod Sci; 2009 Apr; 16(4):373-9. PubMed ID: 19087980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.
    van Wyk L; Boers KE; van der Post JA; van Pampus MG; van Wassenaer AG; van Baar AL; Spaanderdam ME; Becker JH; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Roumen FJ; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 May; 206(5):406.e1-7. PubMed ID: 22444791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.